Stand Up To Cancer Announces Recently Funded Teams Focusing on Lung Cancer Disparities and KRAS Mutant Cancers
May 26, 2022
May 26, 2022
LOS ANGELES, California, May 26 (TNSres) -- The Entertainment Industry Foundation's Stand Up To Cancer issued the following news release on May 25, 2022:
Stand Up To Cancer(R) (SU2C) today announced two new teams, the SU2C Lung Cancer Health Equity Research Team with support from Bristol Myers Squibb and "SU2C Catalyst(R) with support from Mirati Therapeutics." Both teams build on important work being done by unique SU2C research programs focused on improving cancer health . . .
Stand Up To Cancer(R) (SU2C) today announced two new teams, the SU2C Lung Cancer Health Equity Research Team with support from Bristol Myers Squibb and "SU2C Catalyst(R) with support from Mirati Therapeutics." Both teams build on important work being done by unique SU2C research programs focused on improving cancer health . . .